The Magazine for Sleep Professionals
Thursday, July 23, 2026
ProSomnus, a leader in patient-preferred medical devices for the treatment of Obstructive Sleep Apnea (OSA), today announced the results of three studies evaluating its FDA-cleared Oral Appliance Therapy (OAT) devices in the treatment of OSA. ProSomnus will share data in three poster presentations at SLEEP 2022, the Annual Meeting of […]
Eisai Co., Ltd. announced a total of seven poster presentations including the latest data on its in-house discovered orexin receptor antagonist lemborexant (DAYVIGO® CIV) will be given at the 36th annual meeting of the Associated Professional Sleep Societies (SLEEP 2022), to be held from June 4 to June 8, 2022, in Charlotte, NC. […]
Jazz Pharmaceuticals plc announced that the Company and its partners will present 17 new abstracts from across its neuroscience portfolio at SLEEP 2022, the 36th annual meeting of the Associated Professional Sleep Societies (APSS) being held June 4-8, 2022. “Our latest research being presented at SLEEP 2022 provides important insights that benefit […]
By Sean B. Gipson As we are looking at the downward trend of COVID (let’s hope it continues that way), I’ve had the pleasure of finally getting back out into the world. In doing so, I have had the opportunity to attend some of the recent sleep conferences, like The […]
ProSomnus has announced the results of three studies evaluating its oral appliance therapy devices in the treatment of obstructive sleep apnea. ProSomnus presented the data in three poster presentations at the 2022 American Academy of Dental Sleep Medicine (AADSM) Annual Meeting, held from May 13-15 in Dallas, Texas. Emerging data […]
The following email was sent to users on February 3, 2022. We’re writing to you with two important updates about your recalled Philips device.* As always, thank you for your continued patience as we work hard to ensure as many patients as possible can continue safely with their therapy. Our […]
Idorsia Pharmaceuticals, US Inc. has announced that the US Food and Drug Administration (FDA) has approved QUVIVIQ™ (daridorexant) 25 mg and 50 mg for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance1. The FDA approval of QUVIVIQ is based on an extensive […]
The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. Recalled Product Product Names: Puritan Bennett 980 Series Ventilator Model Numbers: See Recall Database Entries Distribution Dates: February 23, 2017 to April 4, 2020 […]
By Dottie Covey-Elleby, BS, RPSGT While the COVID-19 pandemic has highlighted the importance of infection control in sleep centers, the issue transcends the public health emergency and should be an organization-wide priority at all times. An effective infection control program identifies risks, defines mitigation efforts, and measures results. Whether in […]
By David Schwartz, DDS The June 2021 recall notification of positive airway pressure (PAP) machines by Philips has had a significant impact on sleep centers and their patients. While machine repair and replacement efforts are underway, high demand amid supply shortages requires clinicians to adjust both treatment protocols for […]
